Publicaciones en colaboración con investigadores/as de Institute Catalá Oncología (16)

2024

  1. Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry

    Gastric Cancer, Vol. 27, Núm. 1, pp. 131-145

  2. Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON–SEOM registry

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1674-1686

  3. Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 4, pp. 864-871

  4. State of the scientific evidence and recommendations for the management of older patients with gastric cancer

    Journal of Geriatric Oncology, Vol. 15, Núm. 3

2023

  1. The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

    Therapeutic Advances in Medical Oncology, Vol. 15

2012

  1. Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function

    Medical Oncology, Vol. 29, Núm. 3, pp. 2240-2250

2008

  1. Treatment of patients with unresectable squamous head and neck cancer with induction chemotherapy followed by hyperfractionated radiotherapy

    Cancer/Radiotherapie, Vol. 12, Núm. 2, pp. 88-95

2006

  1. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of institut catala d'oncologia in stage III larynx carcinoma

    Laryngoscope, Vol. 116, Núm. 9, pp. 1651-1656

2002

  1. Dynamic filters for the spectral analysis of random signals

    Measurement Techniques, Vol. 45, Núm. 5, pp. 544-551

  2. The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant period

    Bone Marrow Transplantation, Vol. 29, Núm. 9, pp. 737-743

2000

  1. Meningeal carcinomatosis as a cause of partially reversible blindness

    Clinical and Translational Oncology

  2. Tratamientos novedosos en los tumores de celulas germinales de mal pronostico

    Archivos Espanoles de Urologia, Vol. 53, Núm. 6, pp. 517-521

1998

  1. Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: Effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantation

    Transfusion, Vol. 38, Núm. 11-12, pp. 1063-1070

1997

  1. CDC group IV c-2 infection in a stem cell transplant recipient

    Bone Marrow Transplantation, Vol. 20, Núm. 11, pp. 1005-1006

  2. Quimioprevencion en el cancer de cabeza y cuello

    Acta Otorrinolaringologica Espanola, Vol. 48, Núm. 1, pp. 1-4

1996

  1. Typhlitis associated with docetaxel treatment [1]

    Journal of the National Cancer Institute